Obstet & Gynecol:剖宫产前给予抗生素治疗可有效降低院内感染率

2012-08-08 T.Shen 生物谷

近日,来自华盛顿大学医学院的研究者的研究结果指出,在妇女剖宫产手术之前给予抗生素可以明显降低其感染的比率,研究者David表示,我们跟踪观察了8000个妇女长达8年时间,我们可以肯定在剖宫产术之前给予抗生素确实可以阻止感染的发生。相关研究成果刊登在了近日的国际杂志Obsterics & Gynecology上。 这项研究中,研究者在2003年一月至2010年12月之间,进行了剖腹产分娩跟

近日,来自华盛顿大学医学院的研究者的研究结果指出,在妇女剖宫产手术之前给予抗生素可以明显降低其感染的比率,研究者David表示,我们跟踪观察了8000个妇女长达8年时间,我们可以肯定在剖宫产术之前给予抗生素确实可以阻止感染的发生。相关研究成果刊登在了近日的国际杂志Obsterics & Gynecology上。

这项研究中,研究者在2003年一月至2010年12月之间,进行了剖腹产分娩跟踪以及外科部位伤口感染调查,2003年时,感染比率为每100个剖腹产病人中会有9-10人感染,此后,随着医院颁布相关的法规,这种感染率有所降低,直到2010年时,感染比例降低为每100个人感染2人,在8年的跟踪调查过程中,研究者跟踪的8668人中,有303人发生了感染。

研究者指出,卫生政策的相应改变也会明显降低感染的比率,尽管现在医院病人的数量相比之前有所增加。相关研究成果由疾控中心CDC提供支持。

编译自:Timing of Antibiotics Important in Reducing Infections After C-Section

doi:10.1097/AOG.0b013e31825f032a
PMC:
PMID:

Long-term effect of infection prevention practices and case mix on cesarean surgical site infections.

Kittur ND, McMullen KM, Russo AJ, Ruhl L, Kay HH, Warren DK.

OBJECTIVE: : To estimate trends in patient characteristics and obstetric complications in an 8-year cohort of patients undergoing cesarean delivery and to use time series analysis to estimate the effect of infection prevention interventions and secular trends in patient characteristics on postcesarean delivery surgical site infections. METHODS: : A multivariable autoregressive integrated moving average model was used to perform time series analysis on a 96-month retrospective cohort of patients who underwent cesarean delivery (January 2003-December 2010) in a U.S. tertiary care hospital. RESULTS: : We identified 8,668 women who underwent cesarean delivery. Median age was 26 years (range 12-53 years), 3,093 (35.7%) of patients had body mass indexes (BMIs) of 35 or greater, 2,561 (29.5%) were of white race, and 303 (3.5%) had a surgical site infection. Over the study period, there was a significant increase in the proportion of patients who underwent cesarean delivery who had BMIs of 35 or higher, hypertension or mild preeclampsia, and severe preeclampsia or eclampsia. A nonseasonal autoregressive integrated moving average model with a linear trend and no autocorrelation was identified. In the multivariable autoregressive integrated moving average model of postcesarean surgical site infections, implementation of a policy to administer prophylactic antibiotics within 1 hour before incision, instead of at the time of cord clamp, led to a 48% reduction in cesarean delivery surgical site infections (Δ=-5.4 surgical site infections per 100 cesarean deliveries; P<.001). CONCLUSION: : A change in policy to administer prophylactic antibiotics before incision resulted in a significant reduction in postcesarean surgical site infections.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2043802, encodeId=5624204380284, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Mon Dec 24 16:09:00 CST 2012, time=2012-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011148, encodeId=c85b2011148ac, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Fri Jun 21 01:09:00 CST 2013, time=2013-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345180, encodeId=99c913451808f, content=<a href='/topic/show?id=cd305543152' target=_blank style='color:#2F92EE;'>#抗生素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55431, encryptionId=cd305543152, topicName=抗生素治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Aug 10 01:09:00 CST 2012, time=2012-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435196, encodeId=0a681435196c1, content=<a href='/topic/show?id=1ccd983024d' target=_blank style='color:#2F92EE;'>#院内感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98302, encryptionId=1ccd983024d, topicName=院内感染)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Aug 10 01:09:00 CST 2012, time=2012-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1502439, encodeId=293315024396f, content=<a href='/topic/show?id=ef4b2441971' target=_blank style='color:#2F92EE;'>#产前#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24419, encryptionId=ef4b2441971, topicName=产前)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b49a9545081, createdName=qilu_qi, createdTime=Fri Aug 10 01:09:00 CST 2012, time=2012-08-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2043802, encodeId=5624204380284, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Mon Dec 24 16:09:00 CST 2012, time=2012-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011148, encodeId=c85b2011148ac, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Fri Jun 21 01:09:00 CST 2013, time=2013-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345180, encodeId=99c913451808f, content=<a href='/topic/show?id=cd305543152' target=_blank style='color:#2F92EE;'>#抗生素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55431, encryptionId=cd305543152, topicName=抗生素治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Aug 10 01:09:00 CST 2012, time=2012-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435196, encodeId=0a681435196c1, content=<a href='/topic/show?id=1ccd983024d' target=_blank style='color:#2F92EE;'>#院内感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98302, encryptionId=1ccd983024d, topicName=院内感染)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Aug 10 01:09:00 CST 2012, time=2012-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1502439, encodeId=293315024396f, content=<a href='/topic/show?id=ef4b2441971' target=_blank style='color:#2F92EE;'>#产前#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24419, encryptionId=ef4b2441971, topicName=产前)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b49a9545081, createdName=qilu_qi, createdTime=Fri Aug 10 01:09:00 CST 2012, time=2012-08-10, status=1, ipAttribution=)]
    2013-06-21 yhy100200
  3. [GetPortalCommentsPageByObjectIdResponse(id=2043802, encodeId=5624204380284, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Mon Dec 24 16:09:00 CST 2012, time=2012-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011148, encodeId=c85b2011148ac, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Fri Jun 21 01:09:00 CST 2013, time=2013-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345180, encodeId=99c913451808f, content=<a href='/topic/show?id=cd305543152' target=_blank style='color:#2F92EE;'>#抗生素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55431, encryptionId=cd305543152, topicName=抗生素治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Aug 10 01:09:00 CST 2012, time=2012-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435196, encodeId=0a681435196c1, content=<a href='/topic/show?id=1ccd983024d' target=_blank style='color:#2F92EE;'>#院内感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98302, encryptionId=1ccd983024d, topicName=院内感染)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Aug 10 01:09:00 CST 2012, time=2012-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1502439, encodeId=293315024396f, content=<a href='/topic/show?id=ef4b2441971' target=_blank style='color:#2F92EE;'>#产前#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24419, encryptionId=ef4b2441971, topicName=产前)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b49a9545081, createdName=qilu_qi, createdTime=Fri Aug 10 01:09:00 CST 2012, time=2012-08-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2043802, encodeId=5624204380284, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Mon Dec 24 16:09:00 CST 2012, time=2012-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011148, encodeId=c85b2011148ac, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Fri Jun 21 01:09:00 CST 2013, time=2013-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345180, encodeId=99c913451808f, content=<a href='/topic/show?id=cd305543152' target=_blank style='color:#2F92EE;'>#抗生素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55431, encryptionId=cd305543152, topicName=抗生素治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Aug 10 01:09:00 CST 2012, time=2012-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435196, encodeId=0a681435196c1, content=<a href='/topic/show?id=1ccd983024d' target=_blank style='color:#2F92EE;'>#院内感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98302, encryptionId=1ccd983024d, topicName=院内感染)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Aug 10 01:09:00 CST 2012, time=2012-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1502439, encodeId=293315024396f, content=<a href='/topic/show?id=ef4b2441971' target=_blank style='color:#2F92EE;'>#产前#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24419, encryptionId=ef4b2441971, topicName=产前)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b49a9545081, createdName=qilu_qi, createdTime=Fri Aug 10 01:09:00 CST 2012, time=2012-08-10, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2043802, encodeId=5624204380284, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Mon Dec 24 16:09:00 CST 2012, time=2012-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011148, encodeId=c85b2011148ac, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Fri Jun 21 01:09:00 CST 2013, time=2013-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345180, encodeId=99c913451808f, content=<a href='/topic/show?id=cd305543152' target=_blank style='color:#2F92EE;'>#抗生素治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55431, encryptionId=cd305543152, topicName=抗生素治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Aug 10 01:09:00 CST 2012, time=2012-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1435196, encodeId=0a681435196c1, content=<a href='/topic/show?id=1ccd983024d' target=_blank style='color:#2F92EE;'>#院内感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98302, encryptionId=1ccd983024d, topicName=院内感染)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Aug 10 01:09:00 CST 2012, time=2012-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1502439, encodeId=293315024396f, content=<a href='/topic/show?id=ef4b2441971' target=_blank style='color:#2F92EE;'>#产前#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24419, encryptionId=ef4b2441971, topicName=产前)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b49a9545081, createdName=qilu_qi, createdTime=Fri Aug 10 01:09:00 CST 2012, time=2012-08-10, status=1, ipAttribution=)]
    2012-08-10 qilu_qi

相关资讯

32届母胎医学会:剖宫产无益于改善早产儿结局

    约翰霍普金斯大学的Erika F. Werner医生在在第32届母胎医学会(SMFM)年会(2012. 2. 6-2. 11 美国达拉斯)上的报告,在早产的小于胎龄儿病例中,剖宫产的发生率较高,但根据对1995~2003年间接近3,000例新生儿出生数据的回顾性研究结果,在这一群体中,较阴道分娩,剖宫产并降低早产儿并发症的发生率,并且剖宫产与呼吸窘迫的发生率增高相关。   对于